This month's journal based article is titled: Outcomes Analysis of Y90 Radioembolization for Tumors Other Than Metastatic Colorectal Cancer from the RESiN (Raditaion-Emitting SIR-spheres in Non-resectable Liver Tumors) Registry

Following completion of this CME activity, the participant will be able to:

• Understand when to consider hepatic radioembolization for m-nonCRC metastases.
• Describe the overall survival in this patient population and which patients may benefit more or less from radioembolization.
• Understand risk factors associated with a poorer progression free survival.

This program is designed to meet the educational needs of interventional radiologists, nurses, techs, and trainees at all levels with special interest in managing patients with secondary liver malignancies.

Authors:

Registry Wenhui Zhou M.D., Ph.D., Rajesh P. Shah M.D., and Daniel Y. Sze M.D., Ph.D

Division of Interventional Radiology, Stanford University Medical Center, Stanford, CA, USA

Liping Du Ph.D.

Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN

Daniel B. Brown M.D.

Division of Interventional Radiology, Vanderbilt University, Nashville, TN, USA

Each article goes through a peer review process to validate that the content is matched to the current or potential scope of our learners and that any disclosures submitted do not introduce a conflict or bias within the scientific article. 

Accreditation Statement: This activity has been planned and implemented in accordance with the Essentials and Standards of the Accreditation Council for Continuing Medical Education (ACCME). The Society of Interventional Radiology (SIR) is accredited by the ACCME to provide continuing medical education for physicians. SIR designates this education activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.